Drug evaluation: Rivoglitazone, a new oral therapy for the treatment of type 2 diabetes

K. Schimke, Timothy Davis

    Research output: Contribution to journalArticle

    14 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)338-344
    JournalCurrent Opinion in Investigational Drugs
    Volume8
    Issue number4
    Publication statusPublished - 2007

    Cite this